Advertisement

HealthDay

October 2019 Briefing – Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CDC: U.S. Life Expectancy Up Slightly, Mortality Lower […]

Read More

October 2019 Briefing – Cardiology

Here are what the editors at HealthDay consider to be the most important developments in Cardiology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Rate of Surgical Bailout Low for TAVR THURSDAY, […]

Read More

October 2019 Briefing – Dermatology

Here are what the editors at HealthDay consider to be the most important developments in Dermatology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Bariatric Surgery Linked to Reduced Risk for Skin […]

Read More

October 2019 Briefing – Diabetes & Endocrinology

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CDC: Prevalence of Diabetes Has Plateaued […]

Read More

October 2019 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Juul Shipped Tainted Products, Lawsuit Alleges THURSDAY, […]

Read More

October 2019 Briefing – Gastroenterology

Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Bariatric Surgery Linked to Reduced Risk for Skin […]

Read More

October 2019 Briefing – HIV & AIDS

Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Syringe Exchange Program Has Positive Impact […]

Read More

October 2019 Briefing – Infectious Disease

Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Early Infectious Diseases Consult May Lower Sepsis […]

Read More

October 2019 Briefing – Neurology

Here are what the editors at HealthDay consider to be the most important developments in Neurology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Cognitive Ability in Childhood Linked to Cognitive Scores […]

Read More

October 2019 Briefing – Nursing

Here are what the editors at HealthDay consider to be the most important developments in Nursing for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Close to 1,900 Cases of Vaping-Linked Lung Illness […]

Read More

October 2019 Briefing – OBGYN & Women’s Health

Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Quarter of Fetal Abnormalities ID’d […]

Read More

October 2019 Briefing – Hematology & Oncology

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Juul Shipped Tainted Products, Lawsuit Alleges […]

Read More

October 2019 Briefing – Ophthalmology

Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. CDC: U.S. Life Expectancy Up Slightly, Mortality Lower […]

Read More

October 2019 Briefing – Orthopedics

Here are what the editors at HealthDay consider to be the most important developments in Orthopedics for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Common Sites of Bone Erosion in Rheumatoid Arthritis […]

Read More

October 2019 Briefing – Pediatrics

Here are what the editors at HealthDay consider to be the most important developments in Pediatrics for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Juul Shipped Tainted Products, Lawsuit Alleges THURSDAY, Oct. […]

Read More

October 2019 Briefing – Psychiatry

Here are what the editors at HealthDay consider to be the most important developments in Psychiatry for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Fetal Exposure to Acetaminophen May Increase Risk for […]

Read More

October 2019 Briefing – Pulmonology

Here are what the editors at HealthDay consider to be the most important developments in Pulmonology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Close to 1,900 Cases of Vaping-Linked Lung Illness […]

Read More

October 2019 Briefing – Rheumatology

Here are what the editors at HealthDay consider to be the most important developments in Rheumatology for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Common Sites of Bone Erosion in Rheumatoid Arthritis […]

Read More

October 2019 Briefing – Surgery

Here are what the editors at HealthDay consider to be the most important developments in Surgery for October 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Bariatric Surgery Linked to Reduced Risk for Skin […]

Read More

For latest news and updates
Email-id is invalid